Chapters

Transcript

Video

What guidance can you give when the F1M CGP profile reveals multiple actionable mutations? Why select targeted therapies when multiple genomic alterations or rearrangements co-exist?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea